Laser therapy versus expectant management for selective fetal growth restriction in monochorionic twins: A systematic review
Prenatal Diagnosis · 2023
DOI: 10.1002/pd.6348 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Prenatal Diagnosis, 2023. Verfasst von Cara Buskmiller und 5 weiteren Autor:innen. Beteiligte Einrichtung: Baylor College of Medicine, Houston, Texas, USA. Hauptthemen laut MEDLINE: Laser Therapy, Perinatal Death. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 27 Literaturangaben.
Abstract (Originalsprache)
Selective fetal growth restriction (sFGR) complicates 10%–26% of monochorionic twins. Treatment options include cord coagulation, expectant management, and fetoscopic laser photocoagulation. This review compared laser to expectant management for situations when cord coagulation is not an option. The MEDLINE, EMBASE, and Cochrane databases were queried for studies that compared laser to expectant management for sFGR. GRADE was used to assess quality prior to meta‐analysis. A random‐effects model was used to generate relative risks. Six studies were included, encompassing 299 pregnancies. One study was randomized and the remainder were retrospective cohorts. Laser is associated with more fetal deaths of the FGR twin compared to expectant management (risk ratio [RR] 2.5, 95% confidence interval [CI] 1.43–4.37, p = 0.001, I 2 = 48%). Neonatal deaths and gestational age at delivery did not differ. Laser was associated with decreased abnormal neuroimaging in the AGA twin (RR 0.25, 95% CI 0.07–0.97, p = 0.05). Neurodevelopmental outcomes did not differ, although these data are limited. Laser causes more fetal deaths of the FGR twin without altering gestational age at delivery or rates of neonatal death. The literature is heterogeneous and the level of bias is high. Randomized trials that address laser for type II sFGR are needed and should include long‐term neurological outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Baylor College of Medicine, Houston, Texas, USA.
ORCID-Profile: Cara Buskmiller, Jessian L Munoz, Magdalena Sanz Cortes, Roopali V Donepudi, Michael A Belfort, Ahmed A Nassr
Zitieren
APA
Buskmiller, C., Munoz, J. L., Cortes, M. S., Donepudi, R. V., Belfort, M. A., & Nassr, A. A. (2023). Laser therapy versus expectant management for selective fetal growth restriction in monochorionic twins: A systematic review. Prenatal Diagnosis. https://doi.org/10.1002/pd.6348
Vancouver
Buskmiller C, Munoz JL, Cortes MS, Donepudi RV, Belfort MA, Nassr AA. Laser therapy versus expectant management for selective fetal growth restriction in monochorionic twins: A systematic review. Prenatal Diagnosis. 2023. doi:10.1002/pd.6348
BibTeX
@article{Buskmiller2023,
author = {Buskmiller, Cara and Munoz, Jessian L and Cortes, Magdalena Sanz and Donepudi, Roopali V and Belfort, Michael A and Nassr, Ahmed A},
title = {Laser therapy versus expectant management for selective fetal growth restriction in monochorionic twins: A systematic review},
journal = {Prenatal Diagnosis},
year = {2023},
doi = {10.1002/pd.6348}
}
EUVIMED